FDA may review MDMA for the treatment of PTSD ...Middle East

News channel - News
FDA may review MDMA for the treatment of PTSD
By Brenda Goodman, CNN (CNN) — The US Food and Drug Administration has been asked to review MDMA, or midomafetamine, the active ingredient in street drugs like ecstasy and molly, along with therapy as a treatment for post-traumatic stress disorder. MDMA is a psychedelic drug known as an entactogen, a class of psychoactive drugs that produce experiences of emotional communion, relatedness and emotional openness. The new application was filed Tuesday by a company called the MAPS Public Benefit Corporation, which has been studying the drug in combination with therapy to treat PTSD. The FDA has 60 days to determine whether the new drug application, or NDA, will be accepted for review and

Hence then, the article about fda may review mdma for the treatment of ptsd was published today ( ) and is available on News channel ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( FDA may review MDMA for the treatment of PTSD )

Apple Storegoogle play

Last updated :

Also on site :